Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HX1408 tablets in recurrent or progressive glioblastoma (Phase I/II, China)
CTR20263132Phase 2Active
- Sponsor
- Haixi New Pharma
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HX1408 in glioblastoma (GBM), sponsored by Haixi New Pharma. Started Aug 2026; status: active.
02
Drugs
HX1408
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on CTR20263132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263132.